Melphalan HCl

Melphalan HCl
Product Description

A niche oncology API used for the treatment of multiple myeloma and ovarian cancer. Melphalan HCl Injection, at high intravenous dosage, is indicated, with or without haematopoietic stem cell transplantation, for the treatment of multiple myeloma and childhood neuroblastoma. Available for all global markets along with DMF support.

Apothecon Pharmaceuticals

  • IN
  • 2018
    On CPHI since
Specifications
  • CAS Registry Number
    3223-07-2

Apothecon Pharmaceuticals

  • IN
  • 2018
    On CPHI since

More Products from Apothecon Pharmaceuticals (23)

  • Sodium Ferric Gluconate Complex

    Product Sodium Ferric Gluconate Complex

    A niche API used in its finished form (injectable) indicated for the treatment of iron deficiency anemia. It is used in patients with kidney disease who are receiving dialysis. Available for all global markets except the US along with DMF support.

  • Phytonadione (Vitamin K1)

    Product Phytonadione (Vitamin K1)

    A niche API used in its finished form (injectable and tablet) indicated for the treatment of vitamin K1 deficiency, and to treat certain bleeding or blood-clotting problems caused by other medicines or medical conditions. Oral grade available for all global markets along with DMF support and injectable...
  • Iron Sucrose Complex

    Product Iron Sucrose Complex

    A niche API from our Iron product portfolio used in its finished form (injectable) indicated for iron deficiency anemia.  Available for all global markets along with DMF support.

  • Argatroban

    Product Argatroban

    A niche API used in its finished form (injectable) indicated for prophylaxis or treatment of thrombosis in adult patients with heparin-induced thrombocytopenia.  Available for all global markets along with DMF support.

  • Bendamustine Hydrochloride Monohydrate

    Product Bendamustine Hydrochloride Monohydrate

    A niche oncology API manufactured by us used ultimately in its finished form (injectable) for the treatment of indolent B-cell non-Hodgkin lymphoma. Available for all global markets along with DMF support
  • Cyclophosphamide Monohydrate

    Product Cyclophosphamide Monohydrate

    A niche oncology API used for the treatment of malignant lymphomas (Stages III and IV of the Ann Arbor staging system), Hodgkin's disease, lymphocytic lymphoma (nodular or diffuse), mixed-cell type lymphoma, histiocytic lymphoma, Burkitt's lymphoma. multiple myeloma.. Available for all global markets ex...
  • Sevelamer Carbonate

    Product Sevelamer Carbonate

    A niche API used in its finished form (tablet) for the treatment of hyperphosphatemia in patients with chronic kidney disease. Available for all global markets along with DMF support.

  • Sevelamer Hydrochloride

    Product Sevelamer Hydrochloride

    A niche API used in its finished form (tablet) for the treatment of hyperphosphatemia in patients with chronic kidney disease. Available for all global markets along with DMF support.

  • Trientine Hydrochloride

    Product Trientine Hydrochloride

    An orphan drug API is used in its finished form (capsules) for the treatment of the rare occurring Wilson’s disease. Available for select markets along with DMF support.

  • Ferric Carboxy Maltose

    Product Ferric Carboxy Maltose

    Ferric carboxymaltose (Ferinject(R)), a novel iron complex that consists of a ferric hydroxide core stabilized by a carbohydrate shell, allows for controlled delivery of iron to target tissues. Administered intravenously, it is effective in the treatment of iron-deficiency anaemia, delivering a replenishme...
  • Miglustat

    Product Miglustat

    Miglustat is a rare drug used majorly for the treatment of Gaucher's disease, (a condition in which a certain fatty substance is not broken down normally in the body and instead builds up in some organs and causes liver, spleen, bone, and blood problems). Miglustat is in a class of medications called enzym...
  • Carmustine

    Product Carmustine

    A niche oncology API used in its finished form (injectable) for the treatment of brain tumors glioblastoma, brainstem glioma, medulloblastoma, astrocytoma, ependymoma, and metastatic brain tumors. Available for all global markets except the US along with DMF support.